The stock's rise snapped a three-day losing streak.
ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...
1d
Barchart on MSNWhat Are Wall Street Analysts’ Target Price for ResMed Stock?ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth opportunities in the sleep apnea market.
Shares of ResMed Inc. RMD slipped 1.03% to $230.58 Tuesday, on what proved to be an all-around great trading session for the ...
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...
Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates ...
Does Warren Buffett Know Something Wall Street Doesn't? He's Done This 1 Thing for the First Time in 30 Years, and It May Be a Warning for Investors. Broadcom Inc. (AVGO) Reports 51% Revenue ...
ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...
Have you been paying attention to shares of ResMed (RMD)? Shares have been on the move with the stock up 12.8% over the past month. The stock hit a new 52-week high of $263.05 in the previous session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results